cvs caremark - Search News

Modern Healthcare · 1d

Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.

NBC News on MSN · 1d

Top three insurers reaped $7.3 billion through their drug middlemen’s markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ prescription price hikes of 1,000% or more.

The Financial Times · 1d

FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

Business Insider · 1d

FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent

The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which it says focuses on

13hon MSN

UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%

CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

penncapital-star2h

Regulator accuses drug middlemen of wild price hikes, possibly steering business to themselves

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

15h

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

FTC says Minnesota-based Optum, et al., inflate cancer drug prices 1,000%

Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...

Hosted on MSN1d

What You Need To Know Ahead of CVS Health's Earnings Release

With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...

Healthcare Dive7d

CVS successfully converts commercial pharmacy contracts to “cost plus” model

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

8d

Zydus announces agreement with CVS Caremark

Zydus Lifesciences announced that it has entered into an agreement with CVS Caremark, a CVS Health (CVS) company, to add Zituvio, Zituvimet and ...

8d

Zydus Lifesciences rises 5% on signing agreement with CVS Caremark; Details

CVS Caremark will add Zydus' ZituvioTM and combination products to its template formulary starting January 1, 2025 ...

Hosted on MSN15h

FTC Slams UnitedHealth (NYSE:UNH), CVS and Cigna PBMs for Inflating Prices by $7.3B

The U.S. Federal Trade Commission (FTC) has slammed pharmacy benefit managers (PBMs) owned by UnitedHealth ($UNH), CVS Health ...

20h

Bernstein Sticks to Their Hold Rating for CVS Health (CVS)

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results